Advanced search
Publication Cover
American Journal on Addictions Volume 2, 1993 - Issue 2
Journal homepage
3
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Crossover Trial of Mazindol for Cocaine Dependence

Thomas R. Kosten Department of Psychiatry, the Substance Abuse Research Center, Yale University School of Medicine, New Haven, CT
,
Marlene Steinberg Department of Psychiatry, the Substance Abuse Research Center, Yale University School of Medicine, New Haven, CT
&
Lonas A. Diakogiannis Department of Psychiatry, the Substance Abuse Research Center, Yale University School of Medicine, New Haven, CT
Pages 161-164 | Received 11 Jun 1992, Accepted 06 Oct 1992, Published online: 10 Jul 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

EdwardB. Perry, Roberto Gil, Deborah Miles, Louise Brenner, Lisa Macdougall, Robin Johnson, Kathleen Degen, Ralitza Gueorguieva, IsmeneL. Petrakis, JohnH. Krystal & D. Cyril D'Souza. (2005) Mazindol Augmentation of Antipsychotic Treatment for Schizophrenic Patients with Comorbid Cocaine Abuse or Dependence. Journal of Dual Diagnosis 1:1, pages 37-47.
Read now
Beth K Boyarsky & Elinore F. McCance-Katz. (2000) Improving the Quality of Substance Dependency Treatment with Pharmacotherapy. Substance Use & Misuse 35:12-14, pages 2095-2125.
Read now
Arthur Margolin, S. Kelly Avants, RobertT. Malison & ThomasR. Kosten. (1997) High‐ and low‐dose Mazindol for cocaine dependence in methadone‐maintained patients: A preliminary evaluation. Substance Abuse 18:3, pages 125-131.
Read now
Arthur Margolin, S. Kelly Avants & Thomas R Kosten. (1995) Mazindol for Relapse Prevention to Cocaine Abuse in Methadone-Maintained Patients. The American Journal of Drug and Alcohol Abuse 21:4, pages 469-481.
Read now
S. Kelly Avants, Arthur Margolin & ThomasR. Kosten. (1994) Cocaine Abuse in Methadone Maintenance Programs: Integrating Pharmacotherapy with Psychosocial Interventions. Journal of Psychoactive Drugs 26:2, pages 137-146.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.